Hypertension in youth is becoming an increasingly important public health issue, with potential long-term cardiovascular and metabolic effects. Accurate early detection of those at risk is key to instituting appropriate preventive intervention. Standard assessments of blood pressure (BP) and risk factor determination do not identify the complicated interactions among predictors for hypertension. This research investigates the use of machine learning (ML) algorithms to forecast BP status—normal, prehypertension, and hypertension—within 1- and 3-year timeframes. Through examination of multiple clinical, genetic, and lifestyle parameters, ML models provide a data-driven solution for discovering important predictors without sacrificing model performance. This review discusses recent developments in ML-based predictive analytics for hypertension, compares algorithmic performance, and considers the implications of AI-powered screening tools in pediatric care.
Hypertension in children and adolescents has received growing interest because of its increasing prevalence and linkage to long-term health complications like cardiovascular disease, kidney impairment, and metabolic disorders. The conventional method of BP screening is through regular measurements and the use of standard growth charts, which may not always detect individuals at risk of developing hypertension. With the fast development of artificial intelligence (AI) and ML, new predictive models present a potential way for early hypertension diagnosis and prevention in children.
ML methods can handle big datasets, find significant patterns, and classify BP status accurately. As opposed to traditional statistical models, ML algorithms are capable of combining heterogeneous variables, such as genetic susceptibility, dietary factors, physical activity, socio-economic determinants, and environmental toxins. This review presents the strength of predictive models based on ML, assesses the prominent algorithms used for hypertension prediction, and discusses the challenges and future trends in the area.
Current literature reports limited data showing that pediatric hypertension is on the rise as a result of sedentary lifestyle, obesity, and changes in diet. Although hypertension in adults is well-researched, hypertension among children is still underdiagnosed because it is mostly asymptomatic. Untreated pediatric hypertension has serious long-term implications, such as atherosclerosis, left ventricular hypertrophy, and early-onset cardiovascular disease. With the provision of effective primary prevention measures, early detection of vulnerable individuals is important in averting subsequent health hazards.
ML algorithms have revolutionized predictive analytics in healthcare by leveraging vast amounts of data to identify hidden patterns. In the context of pediatric hypertension, ML models utilize diverse data sources, including:
Clinical Data: Age, gender, weight, height, and BP measurements.
Genetic and Biomarker Data: Family history, genetic markers, lipid profiles, and inflammatory biomarkers.
Lifestyle Factors: Physical activity levels, dietary patterns, sleep duration, and stress levels.
Environmental and Socioeconomic Factors: Air pollution exposure, socioeconomic status, and urban vs. rural living conditions.
Commonly employed ML algorithms for hypertension prediction include:
Decision Trees and Random Forests: These models provide interpretable decision-making processes and can handle complex interactions between predictors.
Support Vector Machines (SVM): Effective for classification tasks in BP prediction.
Neural Networks and Deep Learning: Capable of detecting intricate patterns in large datasets, though requiring substantial computational resources.
Gradient Boosting Methods (e.g., XGBoost, LightGBM): Achieve high accuracy by optimizing prediction models through iterative learning.
Several studies have identified critical factors associated with pediatric hypertension using ML techniques. Key predictors include:
Obesity and Body Mass Index (BMI): A strong correlation exists between obesity and high BP levels in children and adolescents.
Family History of Hypertension: Genetic predisposition plays a crucial role in early hypertension onset.
Dietary Sodium Intake: High sodium consumption is linked to increased BP, particularly in salt-sensitive individuals.
Physical Inactivity: A sedentary lifestyle significantly elevates the risk of hypertension.
Sleep Patterns: Inadequate sleep duration and poor sleep quality are associated with elevated BP levels.
Validation with retrospective and prospective datasets is needed to guarantee the reliability of ML-based predictive models. Cross-validation methods, like k-fold cross-validation, are widely employed for model performance assessment. External validation with independent datasets also increases the generalizability of such models. Comparative studies of ML-based predictions with conventional risk scoring systems prove the greater accuracy and resilience of ML models in predicting persons at risk of hypertension.
Despite the promising potential of ML in hypertension prediction, several challenges must be addressed:
Data Quality and Availability: Incomplete or biased datasets can impact model performance.
Ethical and Privacy Concerns: The use of sensitive health data necessitates stringent data protection measures.
Interpretability of Models: Some ML algorithms, particularly deep learning models, function as black-box systems, making clinical decision-making challenging.
Integration into Clinical Practice: Implementing ML-based predictive tools into routine healthcare requires validation and acceptance by medical professionals.
As ML technology continues to evolve, future research should focus on:
Developing Explainable AI (XAI): Enhancing model interpretability to improve clinical adoption.
Incorporating Wearable Technology: Continuous monitoring through smart devices can provide real-time BP predictions.
Personalized Intervention Strategies: Tailoring prevention programs based on individual risk profiles.
Collaboration between AI Experts and Clinicians: Bridging the gap between technology and healthcare professionals to ensure effective implementation.
Machine learning provides a robust tool for the prediction of hypertension in children and adolescents, allowing for early detection and tailored interventions. Through the integration of heterogeneous data sources, ML models offer higher accuracy than conventional risk assessment tools. Nevertheless, issues related to data quality, ethical considerations, and model interpretability need to be resolved to improve clinical utility. With ongoing evolution in AI-based healthcare, predictive analytics based on ML possess huge potential in avoiding the incidence of pediatric hypertension and enhancing long-term health outcomes.
1.
In leukemia, allogeneic HCT is beneficial following primary induction failure.
2.
Team finds broken 'brake' on cancer mutation machine.
3.
Omega Fatty Acid Changes Tied to Lower Proliferation Rate in Early Prostate Cancer
4.
Prostate cancer screening program beneficial in top decile of polygenic risk score
5.
Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.
1.
New Research on Craniopharyngioma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
A Closer Look at White Blood Cells in Urine: Uncovering the Causes and Treatments
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
The Mysterious World of Petechiae: Exploring Causes and Treatments
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation